Skip to main content
Top
Gepubliceerd in:

20-05-2021

Health-related quality of life predicts length of hospital stay and survival rates for pediatric patients receiving allogeneic hematopoietic cell transplantation

Auteurs: Ying-Mei Liu, Tang-Her Jaing, Yu-Chuan Wen, Shih-Hsiang Chen, Pei-Yin Weng, Lin Lin, Chia-Ling Wu

Gepubliceerd in: Quality of Life Research | Uitgave 12/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

We examined the association between health-related quality of life (HRQoL) of pediatric patients during hospitalization for allogeneic hematopoietic cell transplantation (HCT) and length of hospital stay, and 1-year survival.

Methods

Primary family caregivers were proxy-assessors for the Pediatric Quality of Life (PedsQL) Stem Cell Transplant Module at three time points: 5-days pre-HCT (T0); 14-days post-HCT (engraftment, T1); and 1-week before hospital discharge (T2). Cox regression analyses determined predictors of the overall 1-year survival after allogeneic HCT.

Results

Thirty-nine eligible caregivers completed all assessments. The mean age of the pediatric patients was 9.07 years (SD = 5.2). PedsQL Stem Cell Transplant Module scores decreased from 71.33 (SD = 13.26) at T0 to 55.41(SD = 13.05) at T1 (p < 0.001) and increased to 68.46 (SD = 13.97) at T2 (p < 0.001). There was no significant difference between scores at T0 and T2. Longer length of hospital stay was associated with children who were younger and had greater relative changes in scores on the caregiver-proxy PedsQL Stem Cell Transplant Module from T0 to T1. PedsQL Stem Cell Transplant Module scores ≥ 58.07 at T2 were associated with higher 1-year survival rates (Hazard Ratio = 0.12, 95% Confidence Interval = 0.02–0.78; p = 0.03).

Conclusion

Our findings suggest that assessment of HRQoL during early HCT can add prognostic value beyond demographic and HCT factors. Understanding the HRQoL status during hospitalization for HCT could help identify pediatric patients with low prospects of 1-year survival in order to provide support interventions to improve HRQoL and survival rates.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Nava, T., Ansari, M., Dalle, J. H., de Heredia, C. D., Güngör, T., Trigoso, E., Falkenberg, U., Bertaina, A., Gibson, B., Jarisch, A., & Balduzzi, A. (2020). Supportive care during pediatric hematopoietic stem cell transplantation: Beyond infectious diseases. A report from workshops on supportive care of the pediatric diseases working party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 55, 1126–1136.CrossRef Nava, T., Ansari, M., Dalle, J. H., de Heredia, C. D., Güngör, T., Trigoso, E., Falkenberg, U., Bertaina, A., Gibson, B., Jarisch, A., & Balduzzi, A. (2020). Supportive care during pediatric hematopoietic stem cell transplantation: Beyond infectious diseases. A report from workshops on supportive care of the pediatric diseases working party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 55, 1126–1136.CrossRef
2.
go back to reference Rangarajan, H. G., Smith, L. C., Stanek, J. R., Hall, M., Abu-Arja, R., Auletta, J. J., & O’Brien, S. H. (2019). Increased health care utilization and costs during allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in adolescents and young adults compared with children: A multicenter study. Biology of Blood and Marrow Transplantation, 25(5), 1031–1038.CrossRef Rangarajan, H. G., Smith, L. C., Stanek, J. R., Hall, M., Abu-Arja, R., Auletta, J. J., & O’Brien, S. H. (2019). Increased health care utilization and costs during allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in adolescents and young adults compared with children: A multicenter study. Biology of Blood and Marrow Transplantation, 25(5), 1031–1038.CrossRef
4.
go back to reference D'Souza, A., Fretham, C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR Summary Slides 2019. Retrieved March 9, 2021, from https://www.cibmtr.org D'Souza, A., Fretham, C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR Summary Slides 2019. Retrieved March 9, 2021, from https://​www.​cibmtr.​org
5.
go back to reference Preussler, J. M., Mau, L. W., Majhail, N. S., Bevans, M., Clancy, E., Messner, C., Parran, L., Pederson, K. A., Ferguson, S. S., Walters, K., & Murphy, E. A. (2019). Caregiver availability and patient access to hematopoietic cell transplantation: Social worker perspectives inform practice. Supportive Care in Cancer, 27(11), 4253–4264.CrossRef Preussler, J. M., Mau, L. W., Majhail, N. S., Bevans, M., Clancy, E., Messner, C., Parran, L., Pederson, K. A., Ferguson, S. S., Walters, K., & Murphy, E. A. (2019). Caregiver availability and patient access to hematopoietic cell transplantation: Social worker perspectives inform practice. Supportive Care in Cancer, 27(11), 4253–4264.CrossRef
6.
go back to reference Minculescu, L., Marquart, H. V., Friis, L. S., Petersen, S. L., Schiødt, I., Ryder, L. P., Andersen, N. S., & Sengeloev, H. (2016). Early natural killer cell reconstitution predicts overall survival in T cell–replete allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 22(12), 2187–2193.CrossRef Minculescu, L., Marquart, H. V., Friis, L. S., Petersen, S. L., Schiødt, I., Ryder, L. P., Andersen, N. S., & Sengeloev, H. (2016). Early natural killer cell reconstitution predicts overall survival in T cell–replete allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 22(12), 2187–2193.CrossRef
7.
go back to reference Wobma, H., Jin, Z., Moscoso, S., Bhatia, M., Broglie, L., George, D., Garvin, J., & Satwani, P. (2020). Risk factors, clinical outcomes, and cost-of-care related to graft failure in pediatric allogeneic hematopoietic cell transplant recipients. Biology of Blood and Marrow Transplantation, 26(7), 1318–1325.CrossRef Wobma, H., Jin, Z., Moscoso, S., Bhatia, M., Broglie, L., George, D., Garvin, J., & Satwani, P. (2020). Risk factors, clinical outcomes, and cost-of-care related to graft failure in pediatric allogeneic hematopoietic cell transplant recipients. Biology of Blood and Marrow Transplantation, 26(7), 1318–1325.CrossRef
8.
go back to reference Broder, M. S., Quock, T. P., Chang, E., Reddy, S. R., Agarwal-Hashmi, R., Arai, S., & Villa, K. F. (2017). The cost of hematopoietic stem-cell transplantation in the United States. American Health & Drug Benefits, 10(7), 366–374. Broder, M. S., Quock, T. P., Chang, E., Reddy, S. R., Agarwal-Hashmi, R., Arai, S., & Villa, K. F. (2017). The cost of hematopoietic stem-cell transplantation in the United States. American Health & Drug Benefits, 10(7), 366–374.
9.
go back to reference Godara, A., Siddiqui, N. S., Munigala, S., Dhawan, R., Kansagra, A. J., Rapoport, A. P., Yared, J. A., & Dahiya, S. (2020). Length of stay and hospital costs for patients undergoing allogeneic stem-cell transplantation. JCO Oncology Practice, 17(3), e355–e368.CrossRef Godara, A., Siddiqui, N. S., Munigala, S., Dhawan, R., Kansagra, A. J., Rapoport, A. P., Yared, J. A., & Dahiya, S. (2020). Length of stay and hospital costs for patients undergoing allogeneic stem-cell transplantation. JCO Oncology Practice, 17(3), e355–e368.CrossRef
10.
go back to reference Kaziunas, E., Hanauer, D. A., Ackerman, M. S., & Choi, S. W. (2016). Identifying unmet informational needs in the inpatient setting to increase patient and caregiver engagement in the context of pediatric hematopoietic stem cell transplantation. Journal of the American Medical Informatics Association, 23(1), 94–104.CrossRef Kaziunas, E., Hanauer, D. A., Ackerman, M. S., & Choi, S. W. (2016). Identifying unmet informational needs in the inpatient setting to increase patient and caregiver engagement in the context of pediatric hematopoietic stem cell transplantation. Journal of the American Medical Informatics Association, 23(1), 94–104.CrossRef
11.
go back to reference Brice, L., Weiss, R., Wei, Y., Satwani, P., Bhatia, M., George, D., Garvin, J., Morris, E., Harrison, L., Cairo, M. S., & Sands, S. A. (2011). Health-related quality of life (HRQoL): The impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation. Pediatric Blood & Cancer, 57(7), 1179–1185.CrossRef Brice, L., Weiss, R., Wei, Y., Satwani, P., Bhatia, M., George, D., Garvin, J., Morris, E., Harrison, L., Cairo, M. S., & Sands, S. A. (2011). Health-related quality of life (HRQoL): The impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation. Pediatric Blood & Cancer, 57(7), 1179–1185.CrossRef
12.
go back to reference Loiselle, K. A., Rausch, J. R., Bidwell, S., Drake, S., Davies, S. M., & Pai, A. L. (2016). Predictors of health-related quality of life over time among pediatric hematopoietic stem cell transplant recipients. Pediatric Blood & Cancer, 63(10), 1834–1839.CrossRef Loiselle, K. A., Rausch, J. R., Bidwell, S., Drake, S., Davies, S. M., & Pai, A. L. (2016). Predictors of health-related quality of life over time among pediatric hematopoietic stem cell transplant recipients. Pediatric Blood & Cancer, 63(10), 1834–1839.CrossRef
13.
go back to reference Shaw, B. E., Brazauskas, R., Millard, H. R., Fonstad, R., Flynn, K. E., Abernethy, A., Vogel, J., Petroske, C., Mattila, D., Drexler, R., & Lee, S. J. (2017). Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer, 123(23), 4687–4700.CrossRef Shaw, B. E., Brazauskas, R., Millard, H. R., Fonstad, R., Flynn, K. E., Abernethy, A., Vogel, J., Petroske, C., Mattila, D., Drexler, R., & Lee, S. J. (2017). Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer, 123(23), 4687–4700.CrossRef
15.
go back to reference Clarke, S. A., Skinner, R., Guest, J., Darbyshire, P., Cooper, J., Vora, A., Urquhart, T., Jenney, M., Powell, J., & Eiser, C. (2011). Clinical outcomes and health-related quality of life (HRQOL) following haemopoietic stem cell transplantation (HSCT) for paediatric leukaemia. Child: Care, Health & Development, 37(4), 571–580. Clarke, S. A., Skinner, R., Guest, J., Darbyshire, P., Cooper, J., Vora, A., Urquhart, T., Jenney, M., Powell, J., & Eiser, C. (2011). Clinical outcomes and health-related quality of life (HRQOL) following haemopoietic stem cell transplantation (HSCT) for paediatric leukaemia. Child: Care, Health & Development, 37(4), 571–580.
16.
go back to reference Liu, Y. M., Jaing, T. H., Chen, Y. C., Tang, S. T., Li, C. Y., Wen, Y. C., Chang, H. L., & Chen, M. L. (2016). Quality of life after hematopoietic stem cell transplantation in pediatric survivors: Comparison with healthy controls and risk factors. Cancer Nursing, 39(6), 502–509.CrossRef Liu, Y. M., Jaing, T. H., Chen, Y. C., Tang, S. T., Li, C. Y., Wen, Y. C., Chang, H. L., & Chen, M. L. (2016). Quality of life after hematopoietic stem cell transplantation in pediatric survivors: Comparison with healthy controls and risk factors. Cancer Nursing, 39(6), 502–509.CrossRef
17.
go back to reference Graef, D. M., Phipps, S., Parris, K. R., Martin-Elbahesh, K., Huang, L., Zhang, H., & Crabtree, V. M. (2016). Sleepiness, fatigue, behavioral functioning, and quality of life in survivors of childhood hematopoietic stem cell transplant. Journal of Pediatric Psychology, 41(6), 600–609.CrossRef Graef, D. M., Phipps, S., Parris, K. R., Martin-Elbahesh, K., Huang, L., Zhang, H., & Crabtree, V. M. (2016). Sleepiness, fatigue, behavioral functioning, and quality of life in survivors of childhood hematopoietic stem cell transplant. Journal of Pediatric Psychology, 41(6), 600–609.CrossRef
18.
go back to reference Lawitschka, A., Güclü, E., Varni, J., Putz, M., Wolff, D., Pavletic, S., Greinix, H., Peters, C., & Felder-Puig, R. (2014). Health-related quality of life in pediatric patients after allogeneic SCT: Development of the PedsQL stem cell transplant module and results of a pilot study. Bone Marrow Transplantation, 49(8), 1093–1097.CrossRef Lawitschka, A., Güclü, E., Varni, J., Putz, M., Wolff, D., Pavletic, S., Greinix, H., Peters, C., & Felder-Puig, R. (2014). Health-related quality of life in pediatric patients after allogeneic SCT: Development of the PedsQL stem cell transplant module and results of a pilot study. Bone Marrow Transplantation, 49(8), 1093–1097.CrossRef
19.
go back to reference Rodgers, C., Wills-Bagnato, P., Sloane, R., & Hockenberry, M. (2015). Health-related quality of life among children and adolescents during hematopoietic stem cell transplant recovery. Journal of Pediatric Oncology Nursing, 32(5), 329–336.CrossRef Rodgers, C., Wills-Bagnato, P., Sloane, R., & Hockenberry, M. (2015). Health-related quality of life among children and adolescents during hematopoietic stem cell transplant recovery. Journal of Pediatric Oncology Nursing, 32(5), 329–336.CrossRef
20.
go back to reference Rodday, A. M., Terrin, N., Leslie, L. K., Graham, R. J., & Parsons, S. K. (2017). Understanding the relationship between child health-related quality of life and parent emotional functioning in pediatric hematopoietic stem cell transplant. Journal of Pediatric Psychology, 42(7), 804–814.CrossRef Rodday, A. M., Terrin, N., Leslie, L. K., Graham, R. J., & Parsons, S. K. (2017). Understanding the relationship between child health-related quality of life and parent emotional functioning in pediatric hematopoietic stem cell transplant. Journal of Pediatric Psychology, 42(7), 804–814.CrossRef
21.
go back to reference Rodday, A. M., Terrin, N., Chang, G., & Parsons, S. K. (2013). Performance of the parent emotional functioning (PREMO) screener in parents of children undergoing hematopoietic stem cell transplantation. Quality of Life Research, 22(6), 1427–1433.CrossRef Rodday, A. M., Terrin, N., Chang, G., & Parsons, S. K. (2013). Performance of the parent emotional functioning (PREMO) screener in parents of children undergoing hematopoietic stem cell transplantation. Quality of Life Research, 22(6), 1427–1433.CrossRef
22.
go back to reference Rodday, A. M., Terrin, N., & Parsons, S. K. (2013). Measuring global health-related quality of life in children undergoing hematopoietic stem cell transplant: A longitudinal study. Health and Quality of Life Outcomes, 11(1), 26.CrossRef Rodday, A. M., Terrin, N., & Parsons, S. K. (2013). Measuring global health-related quality of life in children undergoing hematopoietic stem cell transplant: A longitudinal study. Health and Quality of Life Outcomes, 11(1), 26.CrossRef
23.
go back to reference Terrin, N., Rodday, A. M., & Parsons, S. K. (2015). Joint models for predicting transplant-related mortality from quality of life data. Qual of Life Research, 24(1), 31–39.CrossRef Terrin, N., Rodday, A. M., & Parsons, S. K. (2015). Joint models for predicting transplant-related mortality from quality of life data. Qual of Life Research, 24(1), 31–39.CrossRef
24.
go back to reference Johnston, D. L., Nagarajan, R., Caparas, M., Schulte, F., Cullen, P., Aplenc, R., & Sung, L. (2013). Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: A report from the children’s oncology group. PLoS ONE, 8(9), e74549.CrossRef Johnston, D. L., Nagarajan, R., Caparas, M., Schulte, F., Cullen, P., Aplenc, R., & Sung, L. (2013). Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: A report from the children’s oncology group. PLoS ONE, 8(9), e74549.CrossRef
25.
go back to reference Parsons, S. K., Tighiouart, H., & Terrin, N. (2013). Assessment of health-related quality of life in pediatric hematopoietic stem cell transplant recipients: Progress, challenges and future directions. Expert Review of Pharmacoeconomics & Outcomes Research, 13(2), 217–225.CrossRef Parsons, S. K., Tighiouart, H., & Terrin, N. (2013). Assessment of health-related quality of life in pediatric hematopoietic stem cell transplant recipients: Progress, challenges and future directions. Expert Review of Pharmacoeconomics & Outcomes Research, 13(2), 217–225.CrossRef
26.
go back to reference Wood, W. A., Le-Rademacher, J., Syrjala, K. L., Jim, H., Jacobsen, P. B., Knight, J. M., Abidi, M. H., Wingard, J. R., Majhail, N. S., Geller, N. L., & Rizzo, J. D. (2016). Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer, 122(1), 91–98.CrossRef Wood, W. A., Le-Rademacher, J., Syrjala, K. L., Jim, H., Jacobsen, P. B., Knight, J. M., Abidi, M. H., Wingard, J. R., Majhail, N. S., Geller, N. L., & Rizzo, J. D. (2016). Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer, 122(1), 91–98.CrossRef
27.
go back to reference Schwimmer, J. B., Burwinkle, T. M., & Varni, J. W. (2003). Health-related quality of life of severely obese children and adolescents. JAMA, 289(14), 1813–1819.CrossRef Schwimmer, J. B., Burwinkle, T. M., & Varni, J. W. (2003). Health-related quality of life of severely obese children and adolescents. JAMA, 289(14), 1813–1819.CrossRef
28.
go back to reference Varni, J. W., Burwinkle, T. M., & Seid, M. (2005). The PedsQLTM as a pediatric patient-reported outcome: Reliability and validity of the PedsQLTM Measurement Model in 25,000 children. Expert Review of Pharmacoeconomics & Outcomes Research, 5(6), 705–719.CrossRef Varni, J. W., Burwinkle, T. M., & Seid, M. (2005). The PedsQLTM as a pediatric patient-reported outcome: Reliability and validity of the PedsQLTM Measurement Model in 25,000 children. Expert Review of Pharmacoeconomics & Outcomes Research, 5(6), 705–719.CrossRef
29.
go back to reference Varni, J. W., Burwinkle, T. M., Seid, M., & Skarr, D. (2003). The PedsQLTM* 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambulatory Pediatrics, 3(6), 329–341.CrossRef Varni, J. W., Burwinkle, T. M., Seid, M., & Skarr, D. (2003). The PedsQLTM* 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambulatory Pediatrics, 3(6), 329–341.CrossRef
30.
go back to reference Liu, Y. M., Wen, Y. C., Weng, P. Y., Jaing, T. H., & Chen, S. H. (2020). Effectiveness of a three-stage intervention in reducing caregiver distress during pediatric hematopoietic stem cell transplantation: A randomized controlled trial. Journal of Pediatric Oncology Nursing, 37(6), 377–389.CrossRef Liu, Y. M., Wen, Y. C., Weng, P. Y., Jaing, T. H., & Chen, S. H. (2020). Effectiveness of a three-stage intervention in reducing caregiver distress during pediatric hematopoietic stem cell transplantation: A randomized controlled trial. Journal of Pediatric Oncology Nursing, 37(6), 377–389.CrossRef
31.
go back to reference Gyurkocza, B., & Sandmaier, B. M. (2014). Conditioning regimens for hematopoietic cell transplantation: One size does not fit all. Blood, 124(3), 344–353.CrossRef Gyurkocza, B., & Sandmaier, B. M. (2014). Conditioning regimens for hematopoietic cell transplantation: One size does not fit all. Blood, 124(3), 344–353.CrossRef
32.
go back to reference Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H., Beatty, P., Hows, J., & Thomas, E. D. (1995). 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15(6), 825–828.PubMed Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H., Beatty, P., Hows, J., & Thomas, E. D. (1995). 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15(6), 825–828.PubMed
34.
go back to reference Vetter, T. R. (2017). Fundamentals of research data and variables: The devil is in the details. Anesthesia & Analgesia, 125(4), 1375–1380.CrossRef Vetter, T. R. (2017). Fundamentals of research data and variables: The devil is in the details. Anesthesia & Analgesia, 125(4), 1375–1380.CrossRef
35.
go back to reference Bursac, Z., Gauss, C. H., Williams, D. K., & Hosmer, D. W. (2008). Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine, 3(1), 17.CrossRef Bursac, Z., Gauss, C. H., Williams, D. K., & Hosmer, D. W. (2008). Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine, 3(1), 17.CrossRef
36.
go back to reference Leys, C., Klein, O., Dominicy, Y., & Ley, C. (2018). Detecting multivariate outliers: Use a robust variant of the mahalanobis distance. Journal of Experimental Social Psychology, 74, 150–156.CrossRef Leys, C., Klein, O., Dominicy, Y., & Ley, C. (2018). Detecting multivariate outliers: Use a robust variant of the mahalanobis distance. Journal of Experimental Social Psychology, 74, 150–156.CrossRef
37.
go back to reference Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society, 34(2), 187–202. Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society, 34(2), 187–202.
38.
go back to reference Bishara, A. J., & Hittner, J. B. (2012). Testing the significance of a correlation with nonnormal data: Comparison of Pearson, Spearman, transformation, and resampling approaches. Psychological Methods, 17(3), 399–417.CrossRef Bishara, A. J., & Hittner, J. B. (2012). Testing the significance of a correlation with nonnormal data: Comparison of Pearson, Spearman, transformation, and resampling approaches. Psychological Methods, 17(3), 399–417.CrossRef
39.
go back to reference Martin, P. J., Rizzo, J. D., Wingard, J. R., Ballen, K., Curtin, P. T., Cutler, C., Litzow, M. R., Nieto, Y., Savani, B. N., Schriber, J. R., & Shaughnessy, P. J. (2012). First-and second-line systemic treatment of acute graft-versus-host disease: Recommendations of the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 18(8), 1150–1163.CrossRef Martin, P. J., Rizzo, J. D., Wingard, J. R., Ballen, K., Curtin, P. T., Cutler, C., Litzow, M. R., Nieto, Y., Savani, B. N., Schriber, J. R., & Shaughnessy, P. J. (2012). First-and second-line systemic treatment of acute graft-versus-host disease: Recommendations of the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 18(8), 1150–1163.CrossRef
40.
go back to reference Jamil, M. O., & Mineishi, S. (2015). State-of-the-art acute and chronic GVHD treatment. International Journal of Hematology, 101(5), 452–466.CrossRef Jamil, M. O., & Mineishi, S. (2015). State-of-the-art acute and chronic GVHD treatment. International Journal of Hematology, 101(5), 452–466.CrossRef
41.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). . Lawrence Erlbaum. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). . Lawrence Erlbaum.
42.
go back to reference Chow, S., Shao, J., & Wang, H. (2008). Sample size calculations in clinical research (2nd ed.). . CRC Press. Chow, S., Shao, J., & Wang, H. (2008). Sample size calculations in clinical research (2nd ed.). . CRC Press.
Metagegevens
Titel
Health-related quality of life predicts length of hospital stay and survival rates for pediatric patients receiving allogeneic hematopoietic cell transplantation
Auteurs
Ying-Mei Liu
Tang-Her Jaing
Yu-Chuan Wen
Shih-Hsiang Chen
Pei-Yin Weng
Lin Lin
Chia-Ling Wu
Publicatiedatum
20-05-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 12/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02887-1